Literature DB >> 9269971

Children with Hirschsprung's disease have an abnormal colonic mucus defensive barrier independent of the bowel innervation status.

A Aslam1, R D Spicer, A P Corfield.   

Abstract

The mucus gel layer in the colon plays an important role in the defensive mechanisms against pathogenic organisms. Mucin glycoproteins or mucins are the major component of this gel. We studied the mucins in patients who had Hirschsprung's disease (HD) by colonic mucosal organ culture with radioactive mucin precursors [35S]-sulphate and [3H]-glucosamine. The secreted and cellular mucus fractions were collected after 24-hour incubation, and mucins were purified by gel filtration. The ratio of incorporation of the precursors and their turnover were quantified. Purified mucins were tested against wheat germ agglutinin for total mucin turnover. We used nine aganglionic bowel samples, 10 ganglionic bowel samples from HD patients, and 13 age-matched normal controls. There were no significant differences in the three groups in ratio of incorporation. The turnover with both radioactive precursors was reduced in both aganglionic and ganglionic bowel of HD, these differences were significant in [35S]-sulphate incorporation in the cellular fraction, ganglionic bowel being most affected. Total mucin turnover, as assessed by reactivity with wheat germ aggultinin, was reduced in both HD groups, being significant in the cellular fraction, aganglionic bowel being the most affected. These results signify an abnormal mucus defensive barrier in the colon of HD patients, even in the ganglionic bowel, which is thought to be normal and is retained at the definitive pull-through operation. This abnormality may be an etiological factor in the pathogenesis of enterocolitis of HD.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9269971     DOI: 10.1016/s0022-3468(97)90683-7

Source DB:  PubMed          Journal:  J Pediatr Surg        ISSN: 0022-3468            Impact factor:   2.545


  14 in total

Review 1.  Mucins and mucosal protection in the gastrointestinal tract: new prospects for mucins in the pathology of gastrointestinal disease.

Authors:  A P Corfield; N Myerscough; R Longman; P Sylvester; S Arul; M Pignatelli
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

Review 2.  New insights into the pathogenesis of Hirschsprung's associated enterocolitis.

Authors:  Feilim Murphy; Prem Puri
Journal:  Pediatr Surg Int       Date:  2005-09-30       Impact factor: 1.827

3.  Mucus Barriers to Microparticles and Microbes are Altered in Hirschsprung's Disease.

Authors:  Hasan M Yildiz; Taylor L Carlson; Allan M Goldstein; Rebecca L Carrier
Journal:  Macromol Biosci       Date:  2015-02-02       Impact factor: 4.979

4.  Immunostaining to visualize murine enteric nervous system development.

Authors:  Amanda J Barlow-Anacker; Christopher S Erickson; Miles L Epstein; Ankush Gosain
Journal:  J Vis Exp       Date:  2015-04-29       Impact factor: 1.355

Review 5.  Hirschsprung's associated enterocolitis.

Authors:  Ankush Gosain; Adam S Brinkman
Journal:  Curr Opin Pediatr       Date:  2015-06       Impact factor: 2.856

6.  Probiotics prevent Hirschsprung's disease-associated enterocolitis: a prospective multicenter randomized controlled trial.

Authors:  Xiaolin Wang; Zhi Li; Zhilin Xu; Zhongrong Wang; Jiexiong Feng
Journal:  Int J Colorectal Dis       Date:  2014-11-05       Impact factor: 2.571

7.  Intestinal dysbiosis and bacterial enteroinvasion in a murine model of Hirschsprung's disease.

Authors:  Joseph F Pierre; Amanda J Barlow-Anacker; Christopher S Erickson; Aaron F Heneghan; Glen E Leverson; Scot E Dowd; Miles L Epstein; Kenneth A Kudsk; Ankush Gosain
Journal:  J Pediatr Surg       Date:  2014-08       Impact factor: 2.545

8.  Impaired Cellular Immunity in the Murine Neural Crest Conditional Deletion of Endothelin Receptor-B Model of Hirschsprung's Disease.

Authors:  Ankush Gosain; Amanda J Barlow-Anacker; Chris S Erickson; Joseph F Pierre; Aaron F Heneghan; Miles L Epstein; Kenneth A Kudsk
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  Disparities in the gut metabolome of post-operative Hirschsprung's disease patients.

Authors:  Vera Plekhova; Ellen De Paepe; Katrien Van Renterghem; Myriam Van Winckel; Lieselot Y Hemeryck; Lynn Vanhaecke
Journal:  Sci Rep       Date:  2021-08-09       Impact factor: 4.379

Review 10.  Exploring the role and diversity of mucins in health and disease with special insight into non-communicable diseases.

Authors:  Santosh Kumar Behera; Ardhendu Bhusan Praharaj; Budheswar Dehury; Sapna Negi
Journal:  Glycoconj J       Date:  2015-08-04       Impact factor: 3.009

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.